Fasken Martineau has been involved in two (2) major investigations conducted by the RAMQ for “unauthorized benefits” allegedly paid by manufacturers and/or wholesalers to pharmacists in Quebec. Fasken Martineau advised and represented a drug manufacturer (2011-2013) and a group of pharmacy owners (since 2014) in the context of these two investigations.